Doripenem

多利培南

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDoripenem
Drug Alias Name多尼培南一水合物Doripenem HydrateDoripenemum多尼培南水合物多立培南 +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Carbapenems antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsHospital-acquired pneumoniaPyelonephritisMeningitis +[17] 
Global Approved IndicationsUrinary Tract InfectionsIntraabdominal InfectionsHealthcare-Associated Pneumonia +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2005/07/25
Country/TerritoryBelgiumCanadaUnited States +[27] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co LtdShionogi Co LtdShionogi & Co LtdKanegasaki Plant +[4] 
Inactive CompaniesPeninsula Pharmaceuticals IncJanssen-Cilag International NvPricara, Unit Of Ortho-Mcneil Inc +[6] 
Active IndicationsHospital-acquired pneumoniaBacterial Infections
Inactive IndicationsPyelonephritisMeningitisPancreatitis +[15] 

Other Information

ATC CodeJ01DH04
Related LinksWikipediaDrugBankKEGG